Veterinary Microbiology, Journal Year: 2024, Volume and Issue: 298, P. 110289 - 110289
Published: Oct. 24, 2024
Language: Английский
Veterinary Microbiology, Journal Year: 2024, Volume and Issue: 298, P. 110289 - 110289
Published: Oct. 24, 2024
Language: Английский
Chinese Medicine, Journal Year: 2025, Volume and Issue: 20(1)
Published: March 24, 2025
Abstract In the past, drug research and development has predominantly followed a "single target, single disease" model. However, clinical data show that single-target drugs are difficult to interfere with complete disease network, prone develop resistance low safety in use. The proposal of multi-target therapy (also known as "cocktail therapy") provides new approach for discovery, which can affect reduce adverse reactions by regulating multiple targets. Natural products an important source innovative development, more than half approved small molecule related natural products. there many challenges process products, such active screening, target identification preclinical dosage optimization. Therefore, how good from always been challenge. This article summarizes applications shortcomings technologies product bioactivity clarify mode action (direct/indirect target), dose Moreover, response faced trend interdisciplinary multi-technology integration, strategy "active substances — optimization" is proposed solve key dimensions levels.
Language: Английский
Citations
0Veterinary Microbiology, Journal Year: 2024, Volume and Issue: 298, P. 110289 - 110289
Published: Oct. 24, 2024
Language: Английский
Citations
0